European Journal Of Clinical Pharmacology SCIE

国际简称：EUR J CLIN PHARMACOL 参考译名：欧洲临床药理学杂志

主要研究方向：医学-药学非预警期刊审稿周期：一般,3-8周

《欧洲临床药理学杂志》(European Journal Of Clinical Pharmacology)是一本由Springer Berlin Heidelberg出版的以医学-药学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q3 JCR分区
153 年发文量
2.4 IF影响因子
未开放 是否OA
99 H-index
1968 创刊年份
Monthly 出版周期
English 出版语言

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

-a compound that is interesting and new in some basic or fundamental way, or

-methods that are original in some basic sense, or

-a highly unexpected outcome, or

-conclusions that are scientifically novel in some basic or fundamental sense.

[ 查看全部 ]

投稿咨询加急咨询

European Journal Of Clinical Pharmacology期刊信息

ISSN：0031-6970
出版语言：English
是否OA：未开放
E-ISSN：1432-1041
出版地区：GERMANY
是否预警：否
出版商：Springer Berlin Heidelberg
出版周期：Monthly
创刊时间：1968
开源占比：0.3214
Gold OA文章占比：32.62%
OA被引用占比：0.2584...
出版国人文章占比：0.07
出版撤稿占比：0
研究类文章占比：70.59%

European Journal Of Clinical Pharmacology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.4

0.727

0.99

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q2	92 / 272	66%
大类：Medicine 小类：Pharmacology	Q2	142 / 313	54%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

European Journal Of Clinical Pharmacology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

European Journal Of Clinical Pharmacology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	188 / 354	47%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q3	192 / 354	45.9%

European Journal Of Clinical Pharmacology历年数据统计

影响因子

中科院分区

European Journal Of Clinical Pharmacology中国学者发文选摘

1、The pharmacokinetics and safety of lidocaine in liver cancer patients undergoing hepatic resection
Author: He, Chaoqun; Jin, Ying; Zhang, Yang; Zhang, Mengyu; Di, Xiangjie; Fu, Lisha; Qi, Xiaohui; Liu, Runhan; Zheng, Li; Wang, Zhenlei; Li, Jingdong; Tu, Faping

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00228-023-03498-0
2、Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis
Author: Ma, Shaodi; Qu, Guangbo; Sun, Chenyu; Liu, Haixia; Jiang, Yuemeng; Li, Ning; Wu, Birong; Gao, Juan; Feng, Linya; Xie, Peng; Xia, Weihang; Kim, Na Hyun; Lowe, Scott; Bentley, Rachel; Zhu, Yike; Zhou, Qin; Sun, Yehuan

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 1, pp. 39-61. DOI: 10.1007/s00228-022-03414-y
3、Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis
Author: Hou, Xiaowen; Cen, Kaiwen; Cui, Ying; Zhang, Yuhong; Feng, Xu

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 1, pp. 63-70. DOI: 10.1007/s00228-022-03413-z
4、The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta-analysis
Author: Wei, Jiehua; Xia, Fan; Miao, Junxiang; Wang, Tingting; Chen, Lizhang; Yan, Xuemei

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 1, pp. 1-11. DOI: 10.1007/s00228-022-03416-w
5、A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure
Author: Liao, Ru; Dong, Yalin; Chen, Lihong; Wang, Taotao; Li, Houli; Dong, Haiyan

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 1, pp. 149-157. DOI: 10.1007/s00228-022-03427-7
6、Reliability and feasibility of home-based dried blood spot in therapeutic drug monitoring: a systematic review and meta-analysis
Author: Xiaoyong, Xu; Xilin, Ge; Guangfei, Wang; Wei, Wu; Xiaowen, Zhai; Hong, Xu; Huimin, Zhang; Zhiping, Li

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 2, pp. 183-193. DOI: 10.1007/s00228-022-03417-9
7、Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)-based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials
Author: Sun, Yingchao; Yue, Lei; Hu, Weiling

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 2, pp. 279-288. DOI: 10.1007/s00228-022-03430-y
8、Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis
Author: Li, Xujia; Huang, Jinsheng; Jiang, Chang; Chen, Ping; Quan, Qi; Jiang, Qi; Li, Shengping; Guo, Guifang

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023; Vol. 79, Issue 3, pp. 323-340. DOI: 10.1007/s00228-022-03441-9